Abangah Ghobad, Raughani Alireza, Asadollahi Parisa, Asadollahi Khairollah
Department of Internal Medicine, Faculty of Medicine, Ilam University of Medical Sciences, Ilam, Iran.
Faculty of Medicine, Ilam University of Medical Sciences, Ilam, Iran.
Gastroenterol Hepatol Bed Bench. 2019 Summer;12(3):209-216.
This study compares the effects of two drug regimens for () infection resistant to the first line drug regimen among patients referred to Ilam clinics, Iran.
Single drug regimen is not effective for infection and therefore, application of triple or quadruple drug regimens are currently applied.
This study was performed by a before-after comparative method and patients were randomly selected among those consecutively referred to Ilam gastrointestinal clinics. Patients with failure in the first line treatment, were randomly divided into two equal groups and each group was treated by one of the PPI+Amoxicillin+Rifampicin or PPI+Amoxicillin+Levofloxacin drug regimens for 14 days. Six weeks after treatment, patients were tested for stool antigen and the results were compared between two groups.
In this study, 100 patients including 49 (49%) men and 51 (51%) women were examined. There was no statistical difference between the two groups for gender, age and living location at the start of study (p = 0.068). The mean age of the patients was 44.55 ±15.1 years old ranging from 17 to 85 years. Response to treatment among the levofloxacin group, was 90% and in rifampicin group 72% with a significant difference (p<0.04).
The response rate of infection to the Levofloxacin based regimen was 90%; however, the application of rifampicin in combination with other drugs against infection (72% response rate), should be limited to reduce the possibility of drug resistance in case of tuberculosis infection.
本研究比较了两种药物治疗方案对转诊至伊朗伊拉姆诊所的患者中对一线药物治疗方案耐药的()感染的疗效。
单一药物治疗方案对()感染无效,因此目前应用三联或四联药物治疗方案。
本研究采用前后对比法进行,患者从连续转诊至伊拉姆胃肠诊所的患者中随机选取。一线治疗失败的患者被随机分为两组,每组分别接受PPI + 阿莫西林 + 利福平或PPI + 阿莫西林 + 左氧氟沙星药物治疗方案之一,治疗14天。治疗六周后,对患者进行()粪便抗原检测,并比较两组结果。
本研究共检查了100例患者,其中男性49例(49%),女性51例(51%)。研究开始时,两组在性别、年龄和居住地点方面无统计学差异(p = 0.068)。患者的平均年龄为44.55±15.1岁,年龄范围为17至85岁。左氧氟沙星组的治疗有效率为90%,利福平组为72%,差异有统计学意义(p<0.04)。
基于左氧氟沙星的治疗方案对()感染的有效率为90%;然而,利福平与其他抗()感染药物联合应用(有效率72%)应加以限制,以降低结核病感染时产生耐药性的可能性。